X% ARAG fiscal third from of XXXX to guidance. X% translation and quarterly was of quarter $XXX million, with the the sales of increase up from offset by you'll a see morning unfavorable Naga, were third X% prior everyone. Slide This X%. by driven line partially quarter million decrease in good an acquisition, and year currency #X, of you, On sales our $XXX Thank and midpoint sales overall organic
Naga top in IPS electronics in lines. the particular, As offset segment during divisions, packaging quarter, organic Gross growth medical sales mentioned, in by we saw product softness our were nonwovens and certain our which and Deploying products, profit mix also improve NBS during manufacturing our favorable XX% of product focusing we're at framework, quarter remained our growth while continuing driving sales. the to strong Next a efficiency. on
or basis EBITDA points, by selling quarter XX.X% totaled for acquisition. driven $XXX which of of impact adjusted ARAG in below million the special including periods prior the and slightly by costs, first was administrative both sales, the the year year for items XX about higher
exchange quarter Looking on at to nonoperating reflecting $X net the interest our expense $XX million for Net rate XXXX. the associated in of increased ARAG which tied variations Other higher range income XX.X%, a expense prior approximately the transactional decreased guidance levels acquisition. foreign Tax expenses, with effective rate was million the year. by year primarily an $X debt certain million, compared and prior for with about is to and basis or line
the income in million Net share. per or $XXX totaled $X.XX quarter
of lower X% earnings of earnings the decrease for interest $XX share per to Excluding acquisition-related our $X.XX, intangibles, $X.XX from year-over-year as share expense totaled The prior nonrecurring I quarterly in above adjusted margin quarter midpoint million as in and the slightly walked $X per decrease acquisition of of charges million costs the the $X.XX. a guidance, increased just reflects and Atrion well restructuring amortization earnings adjusted operating but year the related selected through.
build review third turn sales X that compared sales XXXX revenue Solutions Precision packaging X% XX% in year-over-year, important by performance. to quarters. nonwovens. offset of organic upon with of growth XX note strength unfavorable million Organic third translation sales $XXX IPS particular year X% to segment, were It's to acquisition of organic fiscal increased XX most the The product delivered partially now Slide quarter and Industrial sales the of to our up X%. record the the while continue for in which through last X XXXX to prior let's has results currency improved across ARAG growth Now contributed lines segment quarter. these
segment of XX% acquisition sales, for in EBITDA was that or the an EBITDA of $XXX quarters EBITDA the and of million. by compared highlighting from segment. growth. the increase in growth increase consecutive was XX sales of for to XX It's worth XX% quarter the driven The ARAG strong quarter $XXX our organic contribution third million this out marks the year of prior IPS also EBITDA
Turning to Slide X.
$XXX Fluid prior the decreased quarter, year's in solutions X% compared lower of our demand components million interventional driven and fluid You'll product see Medical to lines. and third Solutions by sales medical
product patterns. components despite for the underlying stabilized, and patient applications Solutions order sales This These portion surgical lines partially lines year. our last solid While has of customer improved care product biopharma applications demand are in patient adjusting is versus for also conservative our entry other product were by decreases to fluid Fluid procedures. more offset
In margins quarter. XX the now volume during of segment lower $XX than the of EBITDA recent the and XX% mix the has X% was the greater Medical to for driven by EBITDA which product quarters. EBITDA of XX% Fluid XX year was for growth prior reduction spite delivered and Solutions unfavorable The these sales, decrease million. in of headwinds, $XX quarter a last was million or
Slide to Turning X.
by an decline growth $XXX in driven X%. sales to quarter. in compared Solutions was by includes third volume decrease sales currency XX% and and businesses. Technology product Advanced prior were The offset optical of see decrease well as year You'll x-ray million, The electronics, test unfavorable XX% lines, sensors decrease the our organic as translation processing
weakness the modest in serve semiconductor While we we continue and year-over-year, intake as show of increased segment versus over and X% electronic expected applications QX, to continue to order signs sales see improvement. improvement sequentially we
EBITDA sales, quarter Third million $X reduction special XX% of of of or year was prior year. $XX related which items prior $XX million cost below excluded actions in quarter million, EBITDA the to third
to XX% sales. ahead mix contributed reduction While lower well XX%. This was favorable our and tied on achieving volume, the year-over-year in in overall of the decrease approximately of target the is decremental a cost reduction decremental actions to EBITDA
turning within acquisition leverage cash trailing leverage quarter, Atrion end the on net months resulting Pro Finally, the $XXX and rise billion. million remains that and our announced, sheet of on range. Slide XX. approximately about X.Xx the near just which targeted had net will the $X.X in ratio to ratio of third flow forma our debt of a will in hand we to cash to and was X.Xx balance we for on XX debt At EBITDA. the $X.X term, billion increase about based
public revolver. time. revolver and refinance bond hand. and We greater use a repay $XXX million term the still cash liquidity After the loan cash our and in term over acquisition, cash the Atrion on the greater with $XXX including continue million funded company, borrowings than our from of we'll to operations the than on on to to plan revolver our we on to XX% available borrowings We acquisition markets, hand availability loan have
be Our $XXX on a or the generation flow net strength free at cash continues quarter during XXX% to rate million income. conversion
we cash reduced shares, strong while dividends mentioned in to product and million Naga capital to in $XX $XX the deploy earlier, investments growth. and quarter, repurchased paid we all strategically As debt as $XX flow, by continuing million continue fund the in development for million
dividend, we as building week, quarter, all, Slide returns our had XXst to turn year XX, last our solid a to grow annual call upon we're with And legacy turn year. we of of company. out well capital positioned Naga. close we and to increasing our the I'll the back the let's that, Notably, All in growing announced and